Cargando…
Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients
BACKGROUND: Wingspan stenting for the treatment of complex intracranial atherosclerotic stenosis (ICAS), i.e., that involving tortuous vascular pathways, long (>15 mm) lesions or arterial bifurcations, has a relatively high risk of complications. This retrospective study assessed the safety and e...
Autores principales: | Feng, Zhengzhe, Duan, Guoli, Zhang, Ping, Chen, Lei, Xu, Yi, Hong, Bo, Zhao, Wenyuan, Liu, Jianmin, Huang, Qinghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598959/ https://www.ncbi.nlm.nih.gov/pubmed/26449986 http://dx.doi.org/10.1186/s12883-015-0443-9 |
Ejemplares similares
-
Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019) -
Safety and efficacy of enterprise stenting for symptomatic atherosclerotic severe posterior circulation stenosis
por: Zhou, Zhi-Long, et al.
Publicado: (2023) -
Predictors of hyperperfusion syndrome after stent implantation in symptomatic intracranial atherosclerotic stenosis
por: Yan, Long, et al.
Publicado: (2022) -
Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review
por: Sun, Bowen, et al.
Publicado: (2021) -
Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)